This site uses cookies. By using this site you agree to receiving cookies. View Policy.

221%

Magway is a zero-emissions delivery system. Faster, smarter, safer and cheaper than existing solutions. Our mission is to give you what you want, when you want it, timing deliveries down to the very second. Our research suggests that with large scale adoption, Magway could heavily impact the number of delivery vehicles on the road, which in turn would reduce congestion & pollution.

  • Major long-term contract signed with a global organisation
  • Multiple vehicle peletons tested at speed demonstrating full capacity
  • Consortium for 8km West London route connecting over 1 million people
  • Winner: Future Unicorn Award (Institution of Engineering & Technology)

Idea

Magway's mission is to deliver good(s), not just changing the game but changing the world. Our research suggests that deliveries could be faster, safer, smarter, cheaper, and more sustainable, whilst reducing pollution and congestion by removing delivery vehicles. And with less traffic, cities can be reimagined and designed around people.

The pandemic has seen a 35% rise in UK parcel volumes, forecasted to double annually to 6bn by 2025.

Your investment has enabled us to:

• Complete our operational demonstrator, advancing our development and marketing capability

• Collaborate with National Composite Centre and other high-value manufacturing centres to investigate how to make our pipes and components even more sustainable

• Won IET "Future Unicorn" and West London "Best Start-Up" awards. Featured in high profile events and media

Commercial Development:

• Signed a major long-term contract with a global organisation to install Magway across multiple sites, making its operations more energy efficient and sustainable

• Part of West London net-zero plan with 8km route servicing 1 million+ Londoners. Gaining support from leading names in retail, logistics, and infrastructure to sign up to charter

• Included in Port of Dover's freeport proposal alongside Pfizer, Microsoft & Aston Martin

New funds used to accelerate roll-out, recruitment & allow us to explore Series A funding opportunities.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.

To see the rest of the Magway pitch, join now. It's free, quick and easy.

Due to financial regulations, you need to join our community to view the full investment opportunity.

Join

Already registered?
Log in

Risk warning

Investments of this nature carry risks to your capital, including illiquidity, lack of dividends and dilution. Balance risk with a diversified portfolio. Read more. Approved as a financial promotion by Crowdcube Capital Limited, which is authorised and regulated by the Financial Conduct Authority.

Investment opportunities are not offers to the public and investors must be eligible Crowdcube members. Further restrictions and Crowdcube's limitation of liability are set out in the Investor Terms and Conditions. Please seek independent advice as required as Crowdcube does not give investment or tax advice.

Magway has been given advance assurance by HMRC that the proposed share issue is likely to qualify for Enterprise Investment Scheme (EIS) tax relief.

Tax relief is available to individuals only, with income tax relief currently set at 30 per cent of the cost of the shares for the tax year in which the investment was made. The tax reliefs can also reduce your Capital Gains Tax bill. Read More.

Availability of tax relief depends on your individual and the company’s ongoing circumstances and applicable law.